Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies

Details for Australian Patent Application No. 2011213904 (hide)

Owner Allergan, Inc.

Inventors Nivaggioli, Thierry; Huang, Glenn T.

Agent Davies Collison Cave

Pub. Number AU-A-2011213904

Parent 2005244211

Filing date 25 August 2011

Wipo publication date 15 September 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

8 September 2011 Complete Application Filed

15 September 2011 Application Open to Public Inspection

  Published as AU-A-2011213904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213905-A panel

2011213903-Actuator assembly and bed